Welcome to our dedicated page for EXELON SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EXELON's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EXELON's regulatory disclosures and financial reporting.
Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.
The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.
RICHO ANNA reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Anna Richo reported a compensation-related equity grant and updated deferred holdings. She received 3,720 "2026 Directors Restricted Stock Units" on April 28, 2026, which are scheduled to fully vest and be settled in Exelon common stock on a 1-for-1 basis on April 28, 2027 under the Exelon Long-term Incentive Plan.
The filing also shows 7,930 deferred phantom share equivalents in a non-qualified deferred compensation plan, each linked 1-for-1 to Exelon common stock and payable in cash after her service on the board ends. No open-market buys or sells are reported in this filing.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported an annual equity award and deferred compensation holdings. On April 28, 2026, she received 3,720 2026 Directors Restricted Stock Units under Exelon’s Long-term Incentive Plan, vesting and settling in common stock on a 1-for-1 basis in 2027. She also holds 3,855 deferred phantom share equivalents in a non-qualified deferred compensation plan, payable in cash on a 1-for-1 basis after her service on the board ends.
Jojo Linda P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Linda P. Jojo received a grant of restricted stock units under the Exelon Long-term Incentive Plan. On April 28, 2026, she was awarded 3,720 2026 Directors Restricted Stock Units at a price of $0.00 per unit as compensation, not an open-market purchase.
The RSUs are scheduled to fully vest on April 28, 2027 and will be settled in an equal number of Exelon common shares on a 1-for-1 basis. The award will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the underlying grant.
Exelon Corp director David G. DeWalt received an annual award of 3,720 restricted stock units (RSUs) designated as 2026 Directors Restricted Stock Units. These RSUs were granted as compensation under the Exelon Long-term Incentive Plan.
The award will fully vest on April 28, 2027 and then be settled in Exelon common stock on a 1-for-1 basis, meaning each unit converts into one share. The RSUs will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the original award. Following this grant, DeWalt holds 3,720 of these RSUs directly.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers reported routine equity-based compensation and existing deferred balances. On 2026-04-28, she received a grant of 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will fully vest and be settled in Exelon common stock on a 1-for-1 basis on 2027-04-28, and will also accrue additional stock units through dividend reinvestment that vest with the underlying award.
Rodgers also reported 10,013 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when her service on the board ends. No open-market purchases or sales were reported in this filing.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director William P. Bowers received a compensation-related equity award and reported existing deferred units. On 2026-04-28, he was granted 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will vest and be settled in Exelon common stock on a 1-for-1 basis and will accrue additional stock units through dividend reinvestment.
He also reported 20,158 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. According to the plan, these phantom share equivalents will be settled in cash on a 1-for-1 basis when his service on the board ends.
Vanguard Portfolio Management reports beneficial ownership of 54,847,064 shares of Exelon Corp common stock as of 03/31/2026. This position represents 5.36% of the class and reflects sole dispositive power over the shares, with 181,630 shares of sole voting power.
Exelon Corporation reports that subsidiary PECO Energy has withdrawn its previously filed 2026 electric and natural gas distribution rate review proceedings with the Pennsylvania Public Utility Commission. PECO cites significant financial pressures on households and businesses and a desire to prioritize customer affordability while maintaining safe, reliable service.
Separately, the Maryland Utility RELIEF Act has passed the Maryland General Assembly and, if signed, will modify the regulatory framework for cost recovery for Exelon subsidiaries BGE, Pepco, and DPL in Maryland. In response to these developments, Exelon plans to redeploy and delay certain capital projects and pursue operational efficiencies.
Exelon reaffirms its 2026 Adjusted (non-GAAP) operating earnings guidance of $2.81–$2.91 per share and its expectation that cumulative annualized Adjusted (non-GAAP) operating earnings growth from 2025 to 2029 will be near the top end of the 5–7% range.
Exelon Corp director Bryan K. Segedi received an award of 878 common stock deferred stock units at $49.82 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. Following this grant, he holds 9,451 deferred stock units indirectly, including 72 units acquired through automatic dividend reinvestment.